Tech Company Financing Transactions
Spirox Funding Round
Spirox, based in Menlo Park, scored $18.5 million in funding from Aisling Capital and Venrock.
Transaction Overview
Company Name
Announced On
4/22/2015
Transaction Type
Venture Equity
Amount
$18,500,000
Round
Series B
Investors
Aisling Capital (Lead Investor) (Aftab Kherani)
Venrock (Lead Investor) (Camille Samuels)
Proceeds Purpose
This funding is further validation of our technology which has the potential to provide relief for millions of patients suffering from nasal obstruction.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3475 Edison Way O
Menlo Park, CA 94015
USA
Menlo Park, CA 94015
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Spirox is focused on developing minimally invasive technologies to improve the quality of life for patients with nasal obstruction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Duke Rohlen
Chief Financial Officer
Doug Koo
Chief Medical Officer
Don Gonzalez
Chief Operating Officer
Mike Rosenthal
VP - Manufacturing
Bill Beasley
VP - Marketing
Matt Brokaw
VP - R & D
Scott Baron
Browse more venture capital transactions:
Prev: 4/22/2015: bringhub venture capital transaction
Next: 4/22/2015: Color Genomics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. All VC database entries on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs